[HTML][HTML] Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases

AL Cardoso, A Fernandes, JA Aguilar-Pimentel… - Ageing research …, 2018 - Elsevier
Objective Use of the frailty index to measure an accumulation of deficits has been proven a
valuable method for identifying elderly people at risk for increased vulnerability, disease …

Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes

A Schcolnik-Cabrera, B Oldak, M Juárez… - Apoptosis, 2019 - Springer
Calreticulin (CRT) is a pleiotropic and highly conserved molecule that is mainly localized in
the endoplasmic reticulum. Recently, CRT has gained special interest for its functions …

Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN

HFE Gleitz, AJF Dugourd… - Blood, The Journal …, 2020 - ashpublications.org
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) that leads to
progressive bone marrow (BM) fibrosis. Although the cellular mutations involved in the …

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR …

J Handlos Grauslund, MO Holmström… - Frontiers in …, 2021 - frontiersin.org
Background The calreticulin (CALR) exon 9 mutations that are identified in 20% of patients
with Philadelphia chromosome negative chronic myeloproliferative neoplasms (MPN) …

Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody

D Tvorogov, CAL Thompson‐Peach, J Foßelteder… - EMBO …, 2022 - embopress.org
Calreticulin (CALR) is recurrently mutated in myelofibrosis via a frameshift that removes an
endoplasmic reticulum retention signal, creating a neoepitope potentially targetable by …

The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases

P Eggleton, J De Alba, M Weinreich… - Journal of Cellular …, 2023 - Wiley Online Library
Two major chaperones, calreticulin (CRT) and binding immunoglobulin protein (GRP78/BiP)
dependent on their location, have immunoregulatory or anti‐inflammatory functions …

Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up

MK Larsen, V Skov, L Kjær… - European Journal of …, 2022 - Wiley Online Library
The myeloproliferative neoplasms are associated with chronic kidney disease but whether
clonal haematopoiesis of indeterminate potential (CHIP) is associated with impaired kidney …

Cancer immune therapy for Philadelphia chromosome-negative chronic myeloproliferative neoplasms

MO Holmström, HC Hasselbalch, MH Andersen - Cancers, 2020 - mdpi.com
Philadelphia chromosome-negative chronic myeloproliferative neoplasms (MPN) are
neoplastic diseases of the hematopoietic stem cells in the bone marrow. MPN are …

Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen‐Specific T Lymphocyte Responses against Melanoma

Z Gong, M Chen, J Miao, CJ Han… - Journal of …, 2022 - Wiley Online Library
An endoplasmic reticulum resident protein, calreticulin (CRT), participates in many cellular
processes. CRT is a tumor‐associated antigen with an important role in antitumor immunity …

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs

M Balliu, L Calabresi, N Bartalucci… - Blood …, 2021 - ashpublications.org
Calreticulin (CALR), an endoplasmic reticulum–associated chaperone, is frequently mutated
in myeloproliferative neoplasms (MPNs). Mutated CALR promotes downstream JAK2/STAT5 …